These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Binding domains of the oxytocin receptor for the selective oxytocin receptor antagonist barusiban in comparison to the agonists oxytocin and carbetocin. Gimpl G; Postina R; Fahrenholz F; Reinheimer T Eur J Pharmacol; 2005 Mar; 510(1-2):9-16. PubMed ID: 15740719 [TBL] [Abstract][Full Text] [Related]
24. Development and applications of a broad-coverage, TR-FRET-based kinase binding assay platform. Lebakken CS; Riddle SM; Singh U; Frazee WJ; Eliason HC; Gao Y; Reichling LJ; Marks BD; Vogel KW J Biomol Screen; 2009 Sep; 14(8):924-35. PubMed ID: 19564447 [TBL] [Abstract][Full Text] [Related]
25. Synthesis and characterization of the first fluorescent nonpeptide NPY Y1 receptor antagonist. Schneider E; Keller M; Brennauer A; Hoefelschweiger BK; Gross D; Wolfbeis OS; Bernhardt G; Buschauer A Chembiochem; 2007 Nov; 8(16):1981-8. PubMed ID: 17876753 [TBL] [Abstract][Full Text] [Related]
26. Fluorescence- and bioluminescence-based approaches to study GPCR ligand binding. Stoddart LA; White CW; Nguyen K; Hill SJ; Pfleger KD Br J Pharmacol; 2016 Oct; 173(20):3028-37. PubMed ID: 26317175 [TBL] [Abstract][Full Text] [Related]
30. A dual estrogen receptor TR-FRET assay for simultaneous measurement of steroid site binding and coactivator recruitment. Hilal T; Puetter V; Otto C; Parczyk K; Bader B J Biomol Screen; 2010 Mar; 15(3):268-78. PubMed ID: 20150592 [TBL] [Abstract][Full Text] [Related]
31. Agonist-specific requirement for a glutamate in transmembrane helix 1 of the oxytocin receptor. Wootten DL; Simms J; Massoura AJ; Trim JE; Wheatley M Mol Cell Endocrinol; 2011 Feb; 333(1):20-7. PubMed ID: 21130837 [TBL] [Abstract][Full Text] [Related]
32. Inhibition of oxytocin receptor function by direct binding of progesterone. Grazzini E; Guillon G; Mouillac B; Zingg HH Nature; 1998 Apr; 392(6675):509-12. PubMed ID: 9548257 [TBL] [Abstract][Full Text] [Related]
33. Functional interactions between the oxytocin receptor and the β2-adrenergic receptor: implications for ERK1/2 activation in human myometrial cells. Wrzal PK; Goupil E; Laporte SA; Hébert TE; Zingg HH Cell Signal; 2012 Jan; 24(1):333-41. PubMed ID: 21964067 [TBL] [Abstract][Full Text] [Related]
34. Homogeneous TR-FRET high-throughput screening assay for calcium-dependent multimerization of sorcin. Appelblom H; Nurmi J; Soukka T; Pasternack M; Penttilä KE; Lövgren T; Niemelä P J Biomol Screen; 2007 Sep; 12(6):842-8. PubMed ID: 17579123 [TBL] [Abstract][Full Text] [Related]
35. Time-resolved fluorescence resonance energy transfer kinase assays using physiological protein substrates: applications of terbium-fluorescein and terbium-green fluorescent protein fluorescence resonance energy transfer pairs. Riddle SM; Vedvik KL; Hanson GT; Vogel KW Anal Biochem; 2006 Sep; 356(1):108-16. PubMed ID: 16797477 [TBL] [Abstract][Full Text] [Related]
36. Fluorescent pseudo-peptide linear vasopressin antagonists: design, synthesis, and applications. Durroux T; Peter M; Turcatti G; Chollet A; Balestre MN; Barberis C; Seyer R J Med Chem; 1999 Apr; 42(7):1312-9. PubMed ID: 10197974 [TBL] [Abstract][Full Text] [Related]
37. Homogeneous noncompetitive assay of protein via Förster-resonance-energy-transfer with tryptophan residue(s) as intrinsic donor(s) and fluorescent ligand as acceptor. Liao F; Xie Y; Yang X; Deng P; Chen Y; Xie G; Zhu S; Liu B; Yuan H; Liao J; Zhao Y; Yu M Biosens Bioelectron; 2009 Sep; 25(1):112-7. PubMed ID: 19586766 [TBL] [Abstract][Full Text] [Related]
38. Oxytocin and vasopressin receptor distributions in a solitary and a social species of tuco-tuco (Ctenomys haigi and Ctenomys sociabilis). Beery AK; Lacey EA; Francis DD J Comp Neurol; 2008 Apr; 507(6):1847-59. PubMed ID: 18271022 [TBL] [Abstract][Full Text] [Related]
39. Novel irreversible fluorescent probes targeting the 18 kDa translocator protein: synthesis and biological characterization. Taliani S; Da Pozzo E; Bellandi M; Bendinelli S; Pugliesi I; Simorini F; La Motta C; Salerno S; Marini AM; Da Settimo F; Cosimelli B; Greco G; Novellino E; Martini C J Med Chem; 2010 May; 53(10):4085-93. PubMed ID: 20438080 [TBL] [Abstract][Full Text] [Related]
40. New fluorescent 2-phenylindolglyoxylamide derivatives as probes targeting the peripheral-type benzodiazepine receptor: design, synthesis, and biological evaluation. Taliani S; Simorini F; Sergianni V; La Motta C; Da Settimo F; Cosimelli B; Abignente E; Greco G; Novellino E; Rossi L; Gremigni V; Spinetti F; Chelli B; Martini C J Med Chem; 2007 Jan; 50(2):404-7. PubMed ID: 17228885 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]